Gonadal Hormones Flashcards
Name 3 natural estrogens?
- Estrone (E1)
- Estradiol (E2)
- Estriol (E3)
Where do conjugated estrogens come from?
• Conjugated estrogens are blended equine estrogens
either isolated from the urine of pregnant mares or
synthetically produced.
Name 2 synthetic estrogens?
Steroidal
• Ethinyl estradiol
• Mestranol (pro-drug converted to ethinyl estradiol)
MOA of estrogens?
Mechanism of action
• Estradiol bind to the estrogen receptor to form a
steroid hormone receptor complex
• Hormone-receptor complex → cell nucleus
→ changes in gene expression
Effects of Estrogen: Female maturation, endometrial, and Metabolic?
Female Maturation
• Development of female secondary sex characteristics
Endometrial
• Endometrial proliferation
Metabolic
• The effects of estrogens on selected aspects of mineral,
lipid, carbohydrate, and protein metabolism are
important for understanding their pharmacological
actions.
Effects of Estrogens: Bone, Lipids, and Coagulation?
Bone
• Decreases resorption of bone (increases mass)
Lipids
• Increase in HDL and decrease in LDL
Coagulation
• Increase hepatic production of factors 2, 7, 9 & 10 and fibrinogen
• Decreases antithrombin III activity
• Increases risk of thromboembolic events
Effects of Estrogen: protein synthesis, vasculature, and fluid balance? Other effects?
Protein Synthesis
• Increase in hepatic production of binding proteins eg, SHBG
Vasculature
• Increase production of NO
• Increase production of prostacyclin
Fluid Balance
• Na+ and H20 retention
Other Effects
• Reproductive Function
• Sexual Behavior
• GI Tract
PK of Estrogens?
Route of Delivery
• Oral, parenteral, intravaginally, or transdermal patch
Metabolism
• Conjugation by cytochrome enzymes
• Use enterohepatic circulation (metabolized in liver, excreted in bile, hydrolyzed by intestinal bacteria and reabsorbed as active drug)
Clinical uses of estrogens?
Postmenopausal Hormonal Therapy
• Decreases risk of osteoporosis (does not treat
osteoporosis)
• Reestablishes feedback on hypothalamic control of NE
secretion, leading to decreased frequency of hot flashes
• Reverses postmenopausal atrophy of the vulva, vagina,
urethra, and trigone of the bladder
Primary Hypogonadism
• Treatment begun with estrogen between ages 11-13
• Progestin added after first uterine bleeding
Treatment of Androgen-Dependent Prostate cancer
Oral Contraceptives
Menstrual Abnormalities
Minor AE of estrogens and Contraindications?
Minor • Uterine bleeding • Nausea • Breast tenderness • Melasma • Peripheral edema
Contraindications
• Cytochrome inducers can lead to reduction in efficacy
Moderate to severe AE of Estrogens?
Moderate/Severe • Increased risk of endometrial cancer (can be offset by combining estrogen with progestin) • Increase in frequency of migraines • Cholestasis and gallbladder disease • Hypertension • Thromboembolism • Depression
Names 3 Selective Estrogen Receptor Modulators(SERMS)
Tamoxifen
Raloxifene
Clomiphene
MOA of each SERM?
Mechanism of Action
They bind to estrogen receptors but can act as
antagonists or agonists depending on the tissue.
Tamoxifen – Antagonist in breast tissue; agonist in nonbreast tissues (endometrium, liver, bone)
Raloxifene – Antagonist in uterus and breast tissue;
agonist in the bone (inhibits resorption)
Clomiphene – Antagonist in hypothalamus (prevents
normal feedback inhibition)
Clinical Use of each SERM?
Tamoxifen
• Prevention and treatment of hormone-responsive breast cancer
Raloxifene
• Prevention of hormone-responsive breast cancer
• Prevention and treatment of osteoporosis in postmenopausal
women
Clomiphene
• Treatment of infertility associated with anovulatory
cycles (eg, PCOS)
AE of Tamoxifen?
Tamoxifen
• Hot flashes and nausea
• Endometrial hyperplasia (increased risk of cancer)
• Thromboembolism
AE of Raloxifene?
Raloxifene • Hot flashes and nausea • Leg cramps • Thromboembolism • NO RISK of endometrial hyperplasia